Email This Article
Headlines & Perspectives
ImClone Starts Approval Process for New Cancer Drug
By
Adam Feuerstein
06/28/01 - 01:49 PM EDT
Its IMC-C225 and other "growth blocking" drugs could mean a new multibillion-dollar market.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
Sign up for our FREE newsletters now.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
Find more premium investing ideas